Apogee Therapeutics, Inc. Common Stock — 차트, 가격 및 뉴스 (NASDAQ:APGE) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

Market Capitalization 4.9 B
Employee 261
Founded 2022
CEO N/A
Website www.apogeetherapeutics.com
Headquarter Massachusetts, United States
FIGI BBG01H51WYQ5
Industry 생명공학

총매출

순이익

주당 순이익(기본 EPS)

총부채

잉여 현금 흐름

현금 및 현금성 자산

뉴스

Apogee Therapeutics: Charging Toward Pivotal Eczema Trial With Extended Dosing (APGE)

Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results

Blackstone Backs Apogee With Up To $1.3 Billion

Apogee Therapeutics: Targeting Atopic Dermatitis (NASDAQ:APGE)

Spyre Therapeutics Flies On Takeda-Rivaling Ulcerative Colitis Results

Why Delta, Starbucks and these other stocks were just added to a market-beating ‘fresh money’ list

Apogee Therapeutics: 'Strong Buy' As Zumilokibart Progresses To Next Q2 Milestone (APGE)

APGE Stock Up as Skin Disease Drug Shows Sustained 52-Week Efficacy

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis Transcript

Apogee Therapeutics: Two Shots A Year, One Shot At Disruption (NASDAQ:APGE)

Apogee Therapeutics, Inc. (APGE) Discusses 52-Week Phase 2 APEX Data for Zumilokibart in Moderate to Severe Atopic Dermatitis - Slideshow (NASDAQ:APGE) 2026-03-23

How Apogee, Up Almost 20%, Plans To Take On Rival Regeneron's Eczema Drug